Proteases are ubiquitous to all the living organisms. Their involvement in the life cycle of various disease causing organisms has led them to become a potential target for developing therapeutic agents against life-threatening diseases such as bacterial infection, cancer, malaria and AIDS. This review is mainly focused on the applications of microbial proteases such as serrapeptase, serrazime, lysostaphin, L-asparaginase, L-glutaminase, streptokinase, streptokinase-streptodornase and xiaflex. These enzymes are being used in the treatment of inflammation, respiratory tract disorders, cardiovascular disease and cancer.
No takes yet. Share an insight, caveat, or question.
Chanalia et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: